Accumulation of c-Myc and proteasomes at the nucleoli of cells containing elevated c-Myc protein levels

Journal of Cell Science

Volumn 116, Issue 9, 2003, Pages 1707-1717

  Arabi, Azadeh ^a,b   Rustum, Cecilia ^a,c   Hallberg, Einar ^a   Wright, Anthony P H ^a,b  

^a SÖDERTÖRN UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Degradation; Photobleaching; Proteasome inhibitor; Stability; Transcription factor

Indexed keywords

GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; MYC PROTEIN; PROTEASOME; PROTEASOME INHIBITOR;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; FIBER; INTRACELLULAR TRANSPORT; NONHUMAN; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT;

ANIMALIA;

EID: 0037650101     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.00370     Document Type: Article

References (47)

1. Alberti, S., Demand, J., Esser, C., Emmerich, N., Schild, H. and Hohfeld, J. (2002). Ubiquitylation of BAG-1 suggests a novel regulatory mechanism during the sorting of chaperone substrates to the proteasome. J. Biol. Chem. 277, 45920-45927.
2. Andersen, J. S., Lyon, C. E., Fox, A. H., Leung, A. K., Lam, Y. W., Steen, H., Mann, M. and Lamond, A. I. (2002). Directed proteomic analysis of the human nucleolus. Curr. Biol. 12, 1-11.
3. Anton, L. C., Schubert, U., Bacik, I., Princiotta, M. F., Wearsch, P. A., Gibbs, J., Day, P. M., Realini, C., Rechsteiner, M. C., Bennink, J. R. et al. (1999). Intracellular localization of proteasomal degradation of a viral antigen. J. Cell Biol. 146, 113-124.
4. Axelson, H., Henriksson, M., Wang, Y., Magnusson, K. P. and Klein, G. (1995). The amino-terminal phosphorylation sites of C-MYC are frequently mutated in Burkitt's lymphoma lines but not in mouse plasmacytomas and rat immunocytomas. Eur. J. Cancer 31A, 2099-2104.
5. Bahram, F., von der Lehr, N., Cetinkaya, C. and Larsson, L. G. (2000). c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover. Blood 95, 2104-2110.
6. Baumann, C. T., Ma, H., Wolford, R., Reyes, J. C., Maruvada, P., Lim, C., Yen, P. M., Stallcup, M. R. and Hager, G. L. (2001). The glucocorticoid receptor interacting protein 1 (GRIP1) localizes in discrete nuclear foci that associate with ND10 bodies and are enriched in components of the 26S proteasome. Mol. Endocrinol. 15, 485-500.
7. Brooks, P., Fuertes, G., Murray, R. Z., Bose, S., Knecht, E., Rechsteiner, M. C., Hendil, K. B., Tanaka, K., Dyson, J. and Rivett, J. (2000). Subcellular localization of proteasomes and their regulatory complexes in mammalian cells. Biochem. J. 346 Pt 1, 155-161.
8. Ciechanover, A., DiGiuseppe, J. A., Bercovich, B., Orian, A., Richter, J. D., Schwartz, A. L. and Brodeur, G. M. (1991). Degradation of nuclear oncoproteins by the ubiquitin system in vitro. Proc. Natl. Acad. Sci. USA 88, 139-143.
9. Daigle, N., Beaudouin, J., Hartnell, L., Imreh, G., Hallberg, E., Lippincott-Schwartz, J. and Ellenberg, J. (2001). Nuclear pore complexes form immobile networks and have a very low turnover in live mammalian cells. J. Cell Biol. 154, 71-84.
10. Dang, C. V., Resar, L. M., Emison, E., Kim, S., Li, Q., Prescott, J. E., Wonsey, D. and Zeller, K. (1999). Function of the c-Myc oncogenic transcription factor. Exp. Cell Res. 253, 63-77.
11. Davarinos, N. A. and Pollenz, R. S. (1999). Aryl hydrocarbon receptor imported into the nucleus following ligand binding is rapidly degraded via the cytosplasmic proteasome following nuclear export. J. Biol. Chem. 274, 28708-28715.
12. Demand, J., Alberti, S., Patterson, C. and Hohfeld, J. (2001). Cooperation of a ubiquitin domain protein and an E3 ubiquitin ligase during chaperone/proteasome coupling. Curr. Biol. 11, 1569-1577.
13. DeMartino, G. N. and Slaughter, C. A. (1999). The proteasome, a novel protease regulated by multiple mechanisms. J. Biol. Chem. 274, 22123-22126.
14. Flinn, E. M., Busch, C. M. and Wright, A. P. (1998). myc boxes, which are conserved in myc family proteins, are signals for protein degradation via the proteasome. Mol. Cell Biol. 18, 5961-5969.
15. Floyd, Z. E., Trausch-Azar, J. S., Reinstein, E., Ciechanover, A. and Schwartz, A. L. (2001). The nuclear ubiquitin-proteasome system degrades MyoD. J. Biol. Chem. 276, 22468-22475.
16. Freedman, D. A. and Levine, A. J. (1998). Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol. Cell Biol. 18, 7288-7293.
17. Gavioli, R., Frisan, T., Vertuani, S., Bornkamm, G. W. and Masucci, M. G. (2001). c-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells. Nat. Cell Biol. 3, 283-288.
18. Gregory, M. A. and Hann, S. R. (2000). c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Mol. Cell Biol. 20, 2423-2435.
19. Hager, G. L., Fletcher, T. M., Xiao, N., Baumann, C. T., Muller, W. G. and McNally, J. G. (2000). Dynamics of gene targeting and chromatin remodelling by nuclear receptors. Biochem. Soc. Trans. 28, 405-410.
20. Hann, S. R. and Eisenman, R. N. (1984). Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol. Cell Biol. 4, 2486-2497.
21. Heikkila, R., Schwab, G., Wickstrom, E., Loke, S. L., Pluznik, D. H., Watt, R. and Neckers, L. M. (1987). A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1. Nature 328, 445-449.
22. Henriksson, M., Classon, M., Axelson, H., Klein, G. and Thyberg, J. (1992). Nuclear colocalization of c-myc protein and hsp70 in cells transfected with human wild-type and mutant c-myc genes. Exp. Cell Res. 203, 383-394.
23. Henriksson, M. and Luscher, B. (1996). Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res. 68, 109-182.
24. Koskinen, P. J., Sistonen, L., Evan, G., Morimoto, R. and Alitalo, K. (1991). Nuclear colocalization of cellular and viral myc proteins with HSP70 in myc-overexpressing cells. J. Virol. 65, 842-851.
25. Kourmouli, N., Theodoropoulos, P. A., Dialynas, G., Bakou, A., Politou, A. S., Cowell, I. G., Singh, P. B. and Georgatos, S. D. (2000). Dynamic associations of heterochromatin protein 1 with the nuclear envelope. EMBO J. 19, 6558-6568.
26. Larsson, L. G., Schena, M., Carlsson, M., Sallstrom, J. and Nilsson, K. (1991). Expression of the c-myc protein is down-regulated at the terminal stages during in vitro differentiation of B-type chronic lymphocytic leukemia cells. Blood 77, 1025-1032.
27. Lippincott-Schwartz, J., Snapp, E. and Kenworthy, A. (2001). Studying protein dynamics in living cells. Nat. Rev. Mol Cell Biol. 2, 444-456.
28. Marcu, K. B., Bossone, S. A. and Patel, A. J. (1992). myc function and regulation. Annu. Rev. Biochem. 61, 809-860.
29. Matera, A. G. (1999). Nuclear bodies: multifaceted subdomains of the interchromatin space. Trends Cell Biol. 9, 302-309.
30. Mattsson, K., Pokrovskaja, K., Kiss, C., Klein, G. and Szekely, L. (2001). Proteins associated with the promyelocytic leukemia gene product (PML)-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradation. Proc. Natl. Acad. Sci. USA 98, 1012-1017.
31. Murphy, W., Sarid, J., Taub, R., Vasicek, T., Battey, J., Lenoir, G. and Leder, P. (1986). A translocated human c-myc oncogene is altered in a conserved coding sequence. Proc. Natl. Acad. Sci. USA 83, 2939-2943.
32. Myung, J., Kim, K. B. and Crews, C. M. (2001). The ubiquitin-proteasome pathway and proteasome inhibitors. Med. Res. Rev. 21, 245-273.
33. Palmer, A., Rivett, A. J., Thomson, S., Hendil, K. B., Butcher, G. W., Fuertes, G. and Knecht, E. (1996). Subpopulations of proteasomes in rat liver nuclei, microsomes and cytosol. Biochem. J. 316, 401-407.
34. Pederson, T. (2001). Protein mobility within the nucleus-what are the right moves? Cell 104, 635-638.
35. Pokrovskaja, K., Mattsson, K., Kashuba, E., Klein, G. and Szekely, L. (2001). Proteasome inhibitor induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5. J. Gen. Virol. 82, 345-358.
36. Reits, E. A., Benham, A. M., Plougastel, B., Neefjes, J. and Trowsdale, J. (1997). Dynamics of proteasome distribution in living cells. EMBO J. 16, 6087-6094.
37. Reyes, J. C. (2001). PML and COP1-two proteins with much in common. Trends Biochem. Sci. 26, 18-20.
38. Salghetti, S. E., Kim, S. Y. and Tansey, W. P. (1999). Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J. 18, 717-726.
39. Satou, A., Taira, T., Iguchi-Ariga, S. M. and Ariga, H. (2001). A novel transrepression pathway of c-Myc. Recruitment of a transcriptional corepressor complex to c-Myc by MM-1, a c-Myc-binding protein. J. Biol. Chem. 276, 46562-46567.
40. Spencer, C. A. and Groudine, M. (1991). Control of c-myc regulation in normal and neoplastic cells. Adv. Cancer Res. 56, 1-48.
41. Stenoien, D. L., Patel, K., Mancini, M. G., Dutertre, M., Smith, C. L., O'Malley, B. W. and Mancini, M. A. (2001). FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent. Nat. Cell Biol. 3, 15-23.
42. Tao, W. and Levine, A. J. (1999). P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2. Proc. Natl. Acad. Sci. USA 96, 6937-6941.
43. Wigley, W. C., Fabunmi, R. P., Lee, M. G., Marino, C. R., Muallem, S., DeMartino, G. N. and Thomas, P. J. (1999). Dynamic association of proteasomal machinery with the centrosome. J. Cell Biol. 145, 481-490.
44. Visintin, R., Hwang, E. S. and Amon, A. (1999). Cfi1 prevents premature exit from mitosis by anchoring Cdc14 phosphatase in the nucleolus. Nature 398, 818-823.
45. Wojcik, C., Schroeter, D., Wilk, S., Lamprecht, J. and Paweletz, N. (1996). Ubiquitin-mediated proteolysis centers in HeLa cells: indication from studies of an inhibitor of the chymotrypsin-like activity of the proteasome. Eur. J. Cell Biol. 71, 311-318.
46. Xirodimas, D., Saville, M. K., Edling, C., Lane, D. P. and Lain, S. (2001). Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo. Oncogene 20, 4972-4983.
47. Yin, X., Landay, M. F., Han, W., Levitan, E. S., Watkins, S. C., Levenson, R. M., Farkas, D. L. and Prochownik, E. V. (2001). Dynamic in vivo interactions among Myc network members. Oncogene 20, 4650-4664.